Dosidal · United States
us:authorisation:ANDA215744
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | United States |
|---|---|
| Record | us:authorisation:ANDA215744 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | fda-application: ANDA215744 |
| Source authority | U.S. Food and Drug Administration |
| Read date | |
| authorisation status | application_number: ANDA215744 original_approval: 2023-02-28 products: brand_name: DOCETAXEL dosage_form: INJECTABLE marketing_status: Prescription product_number: 002 route: INJECTION; brand_name: DOCETAXEL dosage_form: INJECTABLE marketing_status: Prescription product_number: 003 route: INJECTION; brand_name: DOCETAXEL dosage_form: INJECTABLE marketing_status: Prescription product_number: 001 route: INJECTION state: current · read 2026-11-15T11:42:22Z · source: U.S. Food and Drug Administration page |
| authorised channel | state: unknown |
| identity | applicant: ALEMBIC application_number: ANDA215744 labelers: Alembic Pharmaceuticals Inc.; Alembic Pharmaceuticals Limited; Baxter Healthcare Corporation state: current · read 2026-11-15T11:42:22Z · source: U.S. Food and Drug Administration page |
| label reference | state: unknown |
| prescription class | marketing_status_terms: Prescription state: current · read 2026-11-15T11:42:22Z · source: U.S. Food and Drug Administration page |
| recalls and notices | state: current · read 2026-11-15T11:42:25Z · source: U.S. Food and Drug Administration page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d530ynkEEYdFFch1KxKGS1z-qxsr2zMJvZV5VPtLZ3mp_83kz9UKO_7DvnfDSjUdmihcn7eTVGdyP10fimJ-gRybwVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/us:authorisation:ANDA215744 · Related records in other markets · Dosidal